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Abstract
Background: By neutralizing the effect of the matrix metalloproteinases (MMPs), the tissue inhibitors of matrix
metalloproteinases (TIMPs) play a critical role in maintaining tissue proteolysis in balance. As the major reactive glial
cell types in the central nervous system (CNS), microglia and astrocytes play fundamental roles in mediating tissue
breakdown and repair. As such, it is important to define the TIMP expression profile in these cells, as well as the
mechanisms of regulation by neuroinflammatory stimuli.
Methods: Primary mixed glial cultures (MGC), pure microglia, and pure astrocytes were used in this study. To study
astrocytes, we employed a recently described pure astrocyte culture system, which has the major advantage of
totally lacking microglia. The three different types of culture were treated with lipopolysaccharide (LPS) or
individual cytokines, and cell culture supernatants assayed for TIMP-1 or TIMP-2 protein expression by western blot.
Results: LPS induced TIMP-1 expression in MGC, but not in pure astrocyte or microglial cultures. When pure
astrocytes were treated with the cytokines IL-1b, IFN-g, TNF or TGF-b1, only IL-1b induced TIMP-1 expression.
Significantly, astrocyte TIMP-1 expression was restored in LPS-treated astrocyte cultures after the addition of
microglia, or conditioned medium taken from LPS-activated microglia (MG-CM). Furthermore, this effect was lost
after depletion of IL-1b from MG-CM. By contrast, TIMP-2 was constitutively expressed by astrocytes, whereas
microglia expressed TIMP-2 only after exposure to serum.
Conclusions: Taken together, these results demonstrate an important concept in glial interactions, by showing
that microglia play a central role in regulating glial cell expression of TIMPs, and identify microglial IL-1b as playing
a key role in mediating microglial-astrocyte communication.
Background
By inhibiting the matrix metalloproteinases (MMPs), the
tissue inhibitors of metalloproteinases (TIMPs) play an
important role in maintaining proteolysis in balance
[1-3]. In addition to this role, increasing evidence sug-
gests that TIMPs also function in a MMP-independent
manner, to regulate different aspects of cell behavior,
including cell survival, cell proliferation, and the regula-
tion of angiogenesis (reviewed in [4]).
Within the central nervous system (CNS), MMPs and
TIMPs play important roles, both during development,
and during the pathogenesis and remodeling that fol-
lows CNS damage [5-8]. The two major reactive glial
cell types in the CNS are microglia and astrocytes. In
light of the major role these cells play during CNS dis-
ease and repair, it is a high priority to define which
MMPs and TIMPs are expressed by these two glial cell
types, and understand how this expression is regulated
during disease pathogenesis. To shed some light on this,
we previously examined TIMP expression at the mRNA
level by RNase protection assay in primary glial cultures.
This showed that while TIMP-2 is constitutively
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microglia, TIMP-1 is much more restricted in its
expression, being expressed in astrocyte-enriched cul-
tures only after stimulation by IL-1b or lipopolysacchar-
ide (LPS) [9]. In these previous studies, we took the
currently acceptable standard approach of using mixed
glial cultures (MGC) to represent astrocytes. Impor-
tantly though, as MGC contain microglia in addition to
astrocytes, it was not possible to determine whether LPS
and IL-1b exert a direct effect on astrocyte TIMP-1 pro-
duction, or whether this effect requires the production
of microglial intermediate factors. Indeed, in light of the
finding that astrocytes express only marginal levels of
the LPS receptor, TLR-4 [10], it seemed more likely that
the influence of LPS was mediated via microglial factors.
Based on these observations, we proposed the hypoth-
esis that LPS promotes astrocyte TIMP-1 expression
through an indirect mechanism, in which LPS induces
microglia to secrete a soluble factor (possibly IL-1b),
which then stimulates astrocyte TIMP-1 expression.
These previous findings indicate the existence of an
important interplay between microglia and astrocytes in
their regulation of gene expression. As it is becoming
clear that astrocytes play important roles in regulating
many aspects of CNS function, including myelination
[11] and microglial reactivity [12], identifying how other
CNS cell types influence astrocyte functions becomes an
important priority.
To gain an improved understanding of the significance
of microglial-astrocyte interactions in these responses,
we recently developed and characterized a novel method
of obtaining pure astrocytes, in which neurospheres con-
taining neural stem cells (NSC) are differentiated into
astrocytes in the presence of 10% fetal bovine serum
(FBS) [13]. This approach yields pure astrocyte cultures,
totally devoid of microglia, thus permitting an analysis
of astrocyte protein expression, not complicated by the
presence of contaminating microglia. We have already
used this system to good effect to demonstrate that
astrocytes and microglia show distinct, non-overlapping
expression profiles of MMPs. Using this improved
method, we found that in contrast to MGC, pure astro-
cyte cultures express a limited repertoire of MMPs,
quite distinct from the microglial pattern, highlighted by
the finding that microglia, not astrocytes express MMP-
9 [13]. This study also showed that in contrast to MGC
or microglia, pure astrocytes appear to be unresponsive
to LPS, showing no alterations in MMP expression pat-
terns, consistent with the finding that astrocytes express
only low levels of the LPS receptor, TLR-4 [10].
The purpose of the current study was to employ the
improved pure astrocyte culture system, and together
with pure microglial cultures, define the expression of
TIMP-1 and TIMP-2 in astrocytes or microglia at the
protein level, and examine how this is regulated by cyto-
kines and LPS. Then, test our hypothesis that the effect
of LPS on astrocyte TIMP-1 expression is mediated via
a microglial-secreted factor, and if so, identify the mole-
cular mechanism responsible.
Methods
Animals
The studies described have been reviewed and approved
by The Scripps Research Institute Institutional Animal
Care and Use Committee. All cell cultures were
obtained from C57Bl/6 mice which were maintained
under pathogen-free conditions in the closed breeding
colony of The Scripps Research Institute (TSRI).
Cell culture
Mixed glial cultures (MGC) were prepared from 0-2 day
old C57Bl/6 mouse pups, as previously described [14],
and maintained in poly-D-lysine coated T75 flasks in
DMEM containing 10% fetal bovine serum (FBS) (all
from Sigma, St. Louis, MO). After 7-10 days, MGC were
shaken for 30 minutes and the supernatant containing
detached microglia was collected. Microglia were
counted by hemocytometer, re-suspended in the shake-
off medium, and plated at a density of 2 × 10
5 cells/well
in poly-D-lysine coated 6-well plates (Nunc, Naperville,
IL). Microglial purity was > 99% as determined by Mac-
1 in flow cytometry. After MGC were harvested of
microglial cells, the MGC were passaged into poly-D-
lysine coated 6-well plates and maintained in DMEM
containing 10% FBS. Pure astrocyte cultures were pre-
pared as previously described [13], by plating neuro-
spheres into poly-D-lysine coated 6-well plates and
maintained in DMEM containing 10% FBS. Astrocyte
purity of these neurosphere-derived cultures was > 99%
as determined by GFAP immunocytochemistry.
Treatment of glial cultures with LPS and cytokines
After microglia were shaken off MGC, they were
allowed to attach overnight, before the medium was
changed next day to serum-free DMEM containing N1-
supplement, L-glutamine and penicillin/streptomycin (all
from Sigma). In experiments designed to evaluate the
role of microglia in promoting TIMP-1 expression in
astrocytes, 0.5 × 10
5 microglia were added per well of
astrocytes. MGC and pure astrocyte cultures were main-
tained in DMEM containing 10% FBS until confluency,
then switched to the same N1-supplemented serum-free
medium. Upon switching to serum-free medium, all
three types of culture received either no treatment, lipo-
polysaccharide (LPS, serotype: E. Coli 0111.B4, 1 μg/ml,
Sigma), IFN-g (10 U/ml, R&D, Minneapolis, MN), IL-1b
(10 ng/ml, Peprotech, Rocky Hill, NJ), TNF-a (20 ng/
ml, Genentech, San Francisco, CA), or TGF-b1( 2 0n g /
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tants were collected for analysis. LPS-activated micro-
glial conditioned medium (MG-CM) was produced and
collected the same way, and filtered through a 0.22 μm
filter before addition to pure astrocyte cultures.
Antibodies
The goat polyclonal antibodies specific for TIMP-1 (AF-
980), TIMP-2 (AF-971), and IL-1b (AF-401-NA) were
obtained from R&D Systems. Sources of other antibo-
dies include: rabbit anti-goat polyclonal antibody (Vec-
tor Labs, Burlingame, CA), mouse anti-GFAP-Cy3
(Sigma, cat. no. C9205, clone G-A-5), rat anti-Mac-1
antibody (BD Pharmingen, La Jolla, CA, cat. no. 553310,
clone M1/70), anti-rat-Alexafluor 488 (Invitrogen, Carls-
bad, CA), and anti-goat-HRP (Pierce, Rockford, IL).
Immunocytochemistry
To investigate the purity of the different glial culture
systems, cells were cultured on fibronectin coated glass
coverslips in DMEM containing 10% FBS. Cells were
washed in PBS and fixed in acid/alcohol (95:5) at -20°C
for 10 minutes, before being washed extensively and
blocked in 5% normal goat serum (NGS) in PBS for 30
minutes. Cells were then incubated with a Mac-1 mono-
clonal antibody for 1 hour at room temperature, washed
and then incubated with anti-rat-Alexafluor 488 for 30
minutes at room temperature. After washing, cells were
incubated with a mouse anti-GFAP-Cy3 conjugated
antibody for 1 hour, washed and then incubated with
the nuclear Hoechst stain (Sigma) for 10 minutes. Cov-
erslips were then washed and mounted in aquamount
(Polysciences, Warrington, PA).
Immunodepletion experiments
LPS-activated MG-CM was immunodepleted of IL-1b by
six successive rounds of immunoprecipitation. Briefly,
the cell culture supernatants were first pre-cleared for
one hour with 30 μl of protein A sepharose beads per
ml of cell lysate. This was followed by six consecutive
immunoprecipitations, in which 4 μlo fg o a ta n t i - I L - 1 b
and 4 μl of rabbit anti-goat antibody were added to a
tube containing 1 ml MG-CM and 30 μl beads. Each ID
was performed for a minimum period of 4 hours, all at
4°C on a rotating platform. For control, the same MG-
CM also underwent a mock immunodepletion contain-
ing 4 μlo fn o r m a lg o a ts e r u ma n d4μl of rabbit anti-
goat antibody. After the last ID, the supernatants were
sterile filtered through a 0.22 μm filter before addition
to pure astrocyte cultures.
Western blotting
Cell culture supernatants were boiled in reducing sam-
ple buffer for 5 minutes before being analysed by 12%
SDS-PAGE (Invitrogen) under reduced conditions. 10 μl
of cell culture supernatants were electro-blotted for 1
hour onto nitrocellulose membranes (Invitrogen),
blocked overnight in 3% non-fat milk in TBS containing
0.1% Tween-20 (Sigma) and probed with the anti-TIMP
or anti-IL-1b antibodies for one hour, before being
washed, then probed with anti-goat-HRP conjugate
(Pierce) for one hour, and then washed extensively. Pro-
tein bands were visualised with the SuperSignal West-
Femto ECL detection system (Pierce) according to the
manufacturers’ instructions. Band intensity was quanti-
fied using the BioRad Imaging system. Results represent
the mean ± SEM of 4 experiments, with each sample
examined in triplicate within each experiment. Statistical
significance was assessed by using Student’stt e s t ,i n
which p < 0.05 was defined as statistically significant.
Results
LPS induces TIMP-1 expression in mixed glial cultures,
but not pure cultures of astrocytes or microglia
In a previous study, we showed that LPS and IL-1b pro-
mote TIMP-1 expression in mixed glial cultures (MGC),
containing astrocytes and microglia, but not in pure
microglial cultures [9]. From this we hypothesized that
LPS promotes microglia to express soluble factors (pos-
sibly IL-1b and/or other factors), which then stimulate
TIMP-1 expression in astrocytes. As the MGC system
contains microglia in addition to astrocytes, it was not
possible to directly test this idea using the MGC system.
However, with the advent of our recently described pure
astrocyte culture system, which is entirely free of micro-
glia [13], it now becomes possible to perform a molecu-
lar dissection of the signals mediated between microglia
and astrocytes. The three different glial culture systems
are shown in Figure 1, with astrocytes and microglia
identified by GFAP and Mac-1 positivity, respectively.
MGC contained both astrocytes and microglia, pure
astrocyte cultures were entirely devoid of microglia,
while pure microglia cultures contained no astrocytes.
All experiments were performed under serum-free con-
ditions, and TIMP protein expression examined by wes-
tern blot of cell culture supernatants. In the first
experiment, we examined TIMP-1 expression in three
different types of culture: MGC, pure astrocytes, or pure
microglia, with or without the addition of LPS. After 2
days incubation, TIMP-1 expression was examined. As
shown in Figure 2A, TIMP-1 expression was never seen
in any of the three types of culture untreated with LPS,
and of the LPS-treated cells, only the MGC expressed
TIMP-1 protein (running at the predicted molecular
weight of 28 kD). This result confirmed our previous
observation (performed at the mRNA level), showing
that MGC express TIMP-1 in response to LPS stimula-
tion, but microglia do not, and also make the important
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LPS stimulation. As MGC contain a mix of astrocytes
and microglia, these results suggest that microglia are
required to mediate the influence of LPS on TIMP-1
expression in astrocytes.
Pure astrocytes express TIMP-1 in the presence of LPS-
activated microglia conditioned medium
To directly test whether microglia or their secreted fac-
tors influence astrocyte TIMP-1 expression, we cultured
pure astrocytes either alone, in the presence of added
microglial cells, or in the presence of microglia
conditioned medium (MG-CM) previously stimulated by
LPS, all cultures being stimulated with LPS. As shown in
Figure 2B, whereas pure astrocyte cultures treated with
LPS expressed no TIMP-1, the addition of microglial
cells or LPS-activated MG-CM promoted robust TIMP-1
expression. This result confirms that microglia are
required to mediate the effect of LPS on astrocyte TIMP-
1 expression, and furthermore shows that the effect is
mediated via a microglial soluble factor. Based on our
previous finding that of a panel of different cytokines
tested, only IL-1b elevated TIMP-1 mRNA levels in
MGC [9], we investigated a number of different cytokines
Figure 1 Defining the cell purity of the three different glial cell culture systems. Mixed glial cultures (MGC), pure astrocytes (Astro) and
pure microglial cultures (MG) were established as described in Materials and Methods, and then analyzed by immunofluorescence for expression
of the astrocyte marker GFAP (Cy3, red) or the microglial marker Mac-1 (AlexaFluor 488, green). Scale bar = 50 μm. Note that MGC contain both
astrocytes and microglia. In contrast, neurosphere-derived pure astrocyte cultures contain only astrocytes with no microglia, whereas pure
microglial cultures contain only microglia.
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astrocyte cultures. Pure astrocytes were treated with IL-
1b,I F N - g,T N Fo rT G F - b1, their supernatants collected
after 2 days, and examined for TIMP-1 expression (see
Figure 2C). Consistent with our previous mRNA data,
this demonstrated that IL-1b was the only factor that
promoted TIMP-1 in pure astrocytes, and furthermore,
showed that none of the cytokines stimulated TIMP-1
expression in microglial cultures (not shown).
IL-1b is the dominant microglial factor responsible for
mediating astrocyte TIMP-1 expression in response to LPS
Having confirmed that IL-1b has a direct effect on
TIMP-1 induction in astrocytes, we next addressed the
question: is IL-1b the major microglial factor that med-
iates the LPS-induction of astrocyte TIMP-1 expression?
To answer this question, we took LPS-activated MG-CM
and removed all the available IL-1b by performing six
successive rounds of immunodepletion with a polyclonal
anti-IL-1b antibody. Following this procedure, we first
established that the immunodepletion had worked, by
examining IL-1b levels in the MG-CM, before and after
this procedure. As shown in Figure 3A, IL-1b was
detected in the MG-CM prior to, but not after IL-1b
immunodepletion, demonstrating that this procedure
effectively removed all IL-1b from the MG-CM. Next, we
examined TIMP-1 expression in pure astrocyte cultures
treated with LPS-activated MG-CM, in which the MG-
CM had either been mock-depleted (control) or really
depleted of IL-1b.A ss h o w ni nF i g u r e s3 Ba n d3 C ,t h i s
demonstrated that removal of IL-1b from the LPS-acti-
vated MG-CM significantly reduced astrocyte TIMP-1
expression (from 365.6 ± 31.0 under control conditions
to 91.2 ± 36.3 units after IL-1b immunodepletion, p <
Figure 2 Analysis of glial cell TIMP-1 expression in response to cytokines and LPS. TIMP-1 expression was examined by western blot of
cell culture supernatants, as described in Materials and Methods. A. The influence of LPS on TIMP-1 expression in the three different types of
glial culture. MGC, astrocytes, and microglial cultures were treated with LPS for 2 days, then cell culture supernatants examined for TIMP-1
expression. Note that cultures not treated with LPS did not express TIMP-1, and TIMP-1 protein (~28 kD band) was induced only in MGC
following LPS stimulation. B. TIMP-1 induction in astrocytes in the presence of activated microglia or MG-CM. Pure astrocyte cultures received
either: LPS, microglia + LPS, or LPS-activated MG-CM. Note that the presence of LPS-activated microglia or LPS-activated MG-CM strongly
induced TIMP-1 expression in astrocytes. C. The influence of cytokines on TIMP-1 expression by astrocytes. Pure astrocyte cultures were treated
with a panel of different cytokines for 2 days, and the supernatants analyzed for TIMP-1 expression. Note that of the cytokines tested, only IL-1b
stimulated TIMP-1 expression in astrocytes.
Welser-Alves et al. Journal of Neuroinflammation 2011, 8:61
http://www.jneuroinflammation.com/content/8/1/61
Page 5 of 100.02) demonstrating that IL-1b is the dominant micro-
glial factor responsible for mediating astrocyte TIMP-1
expression in response to LPS
Under serum-free conditions, astrocytes but not microglia
constitutively express TIMP-2
In parallel with our analysis of TIMP-1 expression in
astrocyte and microglial cultures, we also examined the
expression of TIMP-2 in these cultures. In contrast to
TIMP-1 expression, this demonstrated that TIMP-2 was
expressed at high levels both by MGC and pure astro-
cytes, but not microglia, and furthermore, not affected
by LPS (see Figure 4A). This confirms that astrocytes
constitutively express TIMP-2. To examine whether
TIMP-2 expression was regulated by cytokines, we
examined the same panel of cytokines, as was used in
the TIMP-1 experiment. This showed that TIMP-2
expression in MGC or in pure astrocyte cultures was
not affected by any of the cytokines tested (see Figure
4B). Furthermore, none of the cytokines tested induced
TIMP-2 expression in microglia (not shown).
Serum induces TIMP-2 expression in microglial cultures
Our current study failed to show any TIMP-2 expres-
sion in microglia. This was unexpected in light of our
previous findings using an RNase protection assay
approach, which demonstrated TIMP-2 expression, both
in MGC and in microglia. In fact, this data showed that
Figure 3 Examining the role of microglia-derived IL-1b in promoting astrocyte TIMP-1 expression. A. Determination of IL-1b in LPS-
activated MG-CM. Microglial cultures were treated with LPS for 2 days, then subject to either six rounds of IL-1b immunodepletion, or mock
depletion, as described in Materials and Methods, and samples analyzed for the presence of IL-1b. Note that IL-1b was detected in the LPS-
activated MG-CM before, but not after the IL-1b immunodepletion, demonstrating the effectiveness of the immunodepletion strategy. B and C.
The effect of removing IL-1b from LPS-activated MG-CM on astrocyte TIMP-1 production. Pure astrocyte cultures received either: LPS, microglia +
LPS, LPS-activated MG-CM (mock depleted) or LPS-activated MG-CM depleted of IL-1b. Note that the presence of LPS-activated microglia or LPS-
activated MG-CM strongly induced TIMP-1 expression in astrocytes, but this effect was markedly attenuated after IL-1b removal from the MG-CM.
* p < 0.02.
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In trying to pinpoint the reason for this discrepancy, we
noted that in the first study, the cell cultures were main-
tained in serum-containing medium (10% FBS), while in
the current study, cells were maintained under serum-
free conditions. To test whether serum accounted for
t h ed i f f e r e n c eb e t w e e nt h et w os t u d i e si nm i c r o g l i a l
TIMP-2 expression, we cultured microglia in either
serum-free or serum-containing media for two days,
then examined TIMP-2 expression by western blot. As
shown in Figure 4C, in the absence of serum, microglia
expressed no TIMP-2 protein, while in the presence of
serum, a dramatic increase in TIMP-2 expression was
observed. To exclude the possibility that the TIMP-2
protein was serum-derived, we also examined the pre-
s e n c eo fT I M P - 2i nt h e1 0 %F B S - c o n t a i n i n gm e d i u m
that the cells were grown in; this failed to show any
TIMP-2 protein. Therefore we conclude that serum
strongly induces TIMP-2 expression in microglial cells.
Discussion
I nt h i ss t u d yw eu s e dp u r ec u l t u r e so fa s t r o c y t e so r
microglia to examine the expression of TIMP-1 and
TIMP-2 at the protein level. Consistent with our
Figure 4 Analysis of glial cell TIMP-2 expression in response to cytokines and LPS. TIMP-2 expression was examined by western blot of
cell culture supernatants, as described in Materials and Methods. A. The influence of LPS on TIMP-1 expression in the three different types of
glial culture. MGC, astrocytes, and microglial cultures were treated with LPS for 2 days, then cell culture supernatants examined for TIMP-2
expression. Note that MGC and pure astrocytes constitutively expressed TIMP-2 (~22 kD) band, and this expression was not enhanced by LPS
stimulation. In contrast, microglial cultures did not express TIMP-2. B. The influence of cytokines on TIMP-2 expression by MGC and pure
astrocytes. MGC and pure astrocyte cultures were treated with a panel of different cytokines for 2 days, and the supernatants analyzed for TIMP-
1 expression. Note that both MGC and pure astrocytes constitutively expressed TIMP-2, and this expression level was not significantly affected by
any of the cytokines tested. C. The influence of serum on microglial TIMP-2 expression. Pure microglial cultures were grown either in serum-free
medium or in medium containing 10% FBS. After 2 days, the cell culture supernatants were analyzed for TIMP-2 expression. Note that the
presence of serum strongly induced TIMP-2 expression in microglial cells.
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mRNA level [9], we found that LPS induced TIMP-1
expression in astrocyte-enriched MGC (which contain
microglia in addition to astrocytes), but interestingly,
this effect was not seen in pure astrocyte or microglial
cultures. Significantly, astrocyte TIMP-1 expression was
restored in pure astrocyte cultures after the addition of
microglia, or conditioned medium taken from LPS-acti-
vated microglia (MG-CM), and this effect was lost after
depletion of IL-1b from MG-CM. In contrast, TIMP-2
was constitutively expressed by astrocytes, while micro-
glia expressed TIMP-2 only after exposure to serum.
Taken together, these results demonstrate an important
concept in glial interactions, by showing that microglia
play a central role in regulating glial cell expression of
TIMPs. Most importantly, they provide direct evidence
that LPS promotes astrocyte TIMP-1 expression via an
indirect mechanism in which LPS stimulates microglia
to secrete IL-1b, which then induces astrocyte TIMP-1
expression.
Functions of TIMPs in the CNS
The TIMP family is comprised of four members, TIMP-
1 through TIMP-4 [1,2,4]. TIMPs were initially charac-
terized as naturally-occurring inhibitors of the MMPs
that were important for the maintenance of proteolytic
balance and as such play important roles in a number of
developmental and physiological remodelling processes,
including cell migration, wound healing, neuronal survi-
val and angiogenesis (reviewed in [1,2,4]). The impor-
tance of the protective MMP-neutralizing effect of
TIMP-1 in the CNS is best illustrated by the finding
that TIMP-1 knockout mice display increased levels of
MMP-9 activity, BBB breakdown and size of ischemic
insult following focal cerebral ischemia [15]. In support
of this, a parallel study revealed that adenoviral delivery
of TIMP-1 or TIMP-2 resulted in reduced levels of neu-
ronal death in a model of global cerebral ischemia [16].
TIMP-1 also plays an important MMP-dependent role
in demyelinating disease, as illustrated by increased
levels of demyelination and myelin pathology in TIMP-1
deficient mice in the mouse model of multiple sclerosis,
experimental autoimmune encephalomyelitis (EAE) [17].
In addition to the well-described MMP-dependent
actions, in more recent years, several studies have
demonstrated that TIMPs also have a number of MMP-
independent actions, that include the regulation of cell
growth and cell death (reviewed in [4]). Specifically, it
has been shown that TIMP-2 promotes neuronal differ-
entiation by inhibiting cell proliferation, in an MMP-
independent manner [18,19]. Exactly how these MMP-
independent effects are mediated at the molecular level
is still to be determined. However, studies on endothe-
lial cells, highly relevant because of the influence of
TIMPs on angiogenesis, suggest that TIMPs can bind to
a variety of cell surface receptors, including the vascular
endothelial growth factor (VEGF) receptor-2 [20], and
the a3b1 integrin [21], raising the possibility that
TIMPs signal through these specific receptors.
Recent studies have described two unexpected roles
for TIMP-1 in the regulation of neural cell behaviour.
First, TIMP-1 influences the growth and morphology of
cortical neurons in an MMP-dependent manner; recom-
binant TIMP-1 reduced neurite length while dramati-
cally increasing the size of growth cones [22]. Second, a
series of studies have demons t r a t e dt h a tT I M P - 1p l a y s
an important role in the generation and differentiation
of oligodendrocytes [23]. TIMP-1 knockout mice show
reduced levels of myelin after induction of EAE [17],
whereas mice that express higher levels of TIMP-1 in
their CNS exhibit attenuated demyelination in EAE [24].
This is supported by the observations that TIMP-1 KO
mice show delayed oligodendrocyte differentiation dur-
ing development [23], and that TIMP-1 KO neural stem
cells (NSC) yield significantly fewer oligodendrocytes
compared to wild type, an effect that can be reversed by
the addition of recombinant TIMP-1 [23].
TIMP expression by astrocytes and microglia
In vivo studies show that TIMP expression is more
strongly associated with astrocytes than microglia
[25,26]. In particular, the consensus view is that TIMP-1
expression is astrocyte-specific, and this expression is
highly upregulated during neuroinflammatory states
involving breakdown of the blood-brain barrier and leu-
kocyte infiltration into the CNS [27-30], suggesting that
astrocyte TIMP-1 may play an important role in curtail-
ing the influx of activated infiltrating leukocytes, by
inhibiting the action of the proteolytic enzyme, MMP-9.
This idea is supported by the finding that in a mouse
model of focal cerebral ischemia, TIMP-1 knockout
mice display increased levels of MMP-9 activity, BBB
breakdown and size of ischemic insult [15]. In addition
to TIMP-1, astrocyte expression of TIMP-2 has also
been described in vivo following astrocyte activation
after brain injury [31,32]. Interestingly, TIMP-2 expres-
sion has also been described in microglia following
brain trauma [33]. These findings are in keeping with
our own observations, namely that TIMP-1 appears to
be astrocyte-specific, but TIMP-2 can be expressed by
both astrocytes and microglia.
A small number of studies have also examined TIMP
expression in pure microglial cultures, with mixed
results. One study performed with PCR on human pri-
mary microglia described all four TIMP family members
within microglia [34], and an ELISA study using the
human microglial cell line CHME3 described both
TIMP-1 and TIMP-2 present in microglia [35]. In
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showed that TIMP-1 protein was only present in astro-
cytes, not microglia [36], and our prior study using
RNAse protection assay was entirely consistent with this
finding [9]. Indeed, our current finding lends further
weight to this idea by showing that microglia expressed
no TIMPs under serum-free conditions, but show strong
induction of TIMP-2 only after exposure to serum. This
finding has two important implications. First, it suggests
that some of the differences apparent between the stu-
dies of microglial TIMP expression may be explained by
the use of serum in microglial cultures. All of the above
described studies (including our RNAse protection assay
analysis) used serum-containing media, which may not
be the best representation of the in vivo condition. Of
course, it is also possible that species-species variation
may contribute to these differences. Second, as our data
clearly demonstrates that serum strongly promotes
TIMP-2 expression in microglia, this implies that break-
down of the BBB will trigger microglial TIMP-2 expres-
sion, thereby limiting the destructive power of the
oncoming wave of MMP-9 introduced into the breached
CNS. This is remarkably similar to our previously
described serum-induction of TIMP-1 expression in
astrocytes [9]. Taken together, it suggests that introduc-
tion of serum into the brain induces TIMP expression
in both astrocytes (TIMP-1) and microglia (TIMP-2) as
part of an intrinsic damage limitation program.
One clear point to emerge from this study is that the
bacterial toxin, LPS does not directly stimulate TIMP-1
expression in astrocytes; rather it mediates its effect by
inducing microglia IL-1b expression, which then triggers
astrocyte TIMP-1 expression. This is important because
it demonstrates that microglia play a pivotal protective
role in driving glial TIMP expression in two ways, first,
by upregulating TIMP-2 in response to serum, and sec-
ond, by facilitating astrocyte TIMP-1 expression is
response to bacterial infection. It also shows that the
pro-inflammatory cytokine IL-1b h a st w os i d e st oi t s
character; having not only deleterious effects in the
CNS, but also providing certain important protective
f u n c t i o n s .I nt h ec u r r e n ts t u d yw eh a v es h o w nt h a tI L -
1b is the major microglial secreted factor responsible for
triggering astrocyte TIMP-1 expression. Removal of IL-
1b resulted in a 75% reduction in astrocyte TIMP-1
expression. That astrocytes still showed a small TIMP-1
response might be due to the presence of another factor
within the MG-CM, or alternatively, it could be due to
a failure of our immunodepletion strategy to totally
remove all IL-1b from the MG-CM. In fact, the latter
seems more likely, as it is almost impossible to totally
remove a factor, so that even a small amount of IL-1b
might be capable of eliciting some degree of TIMP-1
response. If true, this suggests that neuroinflammation
in IL-1b knockout mice may result in an absent astro-
cyte TIMP-1 response, and a potentially much stronger
MMP-proteolytic effect.
Conclusions
The aim of this study was to examine whether TIMP-1
and TIMP-2 are expressed in pure cultures of astro-
cytes and microglia, and thend e f i n et h ei n f l u e n c eo f
LPS and cytokines on this expression. While LPS
induced TIMP-1 expressioni na s t r o c y t e - e n r i c h e d
MGC (which contain microglia in addition to astro-
cytes), this effect was not seen in pure astrocyte or
microglial cultures. However, the addition of microglia,
or conditioned medium taken from LPS-activated
microglia (MG-CM) restored astrocyte TIMP-1 expres-
sion, and this effect was lost after depletion of IL-1b
from MG-CM. By contrast, TIMP-2 was constitutively
expressed by astrocytes, and not altered by any of the
factors tested, while microglia expressed TIMP-2 only
after exposure to serum. These results demonstrate an
important concept in glial interactions, by showing
that microglia play a central role in regulating glial cell
expression of TIMPs, and identify microglial IL-1b as
playing a key role in mediating microglial-astrocyte
communication.
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